PRESS RELEASES

Biosota Organics, a trailblazer in the global honey industry, confronts the dual challenges of oversupply and scarcity in the Manuka honey market. While New Zealand grapples with a surplus of lower-grade MGO honey due to increased beekeeping, Australia faces a scarcity of high-grade medicinal Manuka honey. CEO Andrey Zubko attributes this scarcity to weather fluctuations and challenges in achieving optimal conditions for Manuka flower species. Despite industry unpredictability, Biosota stands out with its rare and limited high medicinal Manuka honey range, sourcing additional reserves to meet demand. The company sets a new standard with the release of MGO 2100+, the world's highest MGO Manuka honey, meticulously lab-tested for authenticity.

Embark on a journey with Biosota Organics, an Australian Manuka honey pioneer. Discover MGO 2000+, our rarest honey, exclusively at Sydney Airport. With MGO levels over 2100, this limited-edition comprises only 500 jars—less than 1% of varieties. CEO Andrey Zubko reveals the fusion of nature and science, reminiscent of the wine industry. Uncover the medicinal prowess of MGO 2000+, offering curative compounds for wounds, infections, and antibiotic-resistant challenges. Packaged in our patented MIRON Violetglass jar, this honey transcends culinary delight—it's a health-focused luxury, epitomising Biosota's commitment to excellence. Delve into MGO 2000+ for exclusive health benefits.